The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinical assessment of the Omicron outbreak in Europe and trends in morbidity and mortality from COVID-19 and cancer.
 
Alessio Cortellini
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; MSD Oncology; Roche
Speakers' Bureau - AstraZeneca; Eisai
 
Juan Aguilar-Company
No Relationships to Disclose
 
Rachel Sharkey
No Relationships to Disclose
 
Anna Sureda Balari
Honoraria - Bristol-Myers Squibb; Celgene; Gilead Sciences; Janssen; Janssen-Cilag; Merck Sharp & Dohme; Novartis; Roche; Sanofi; Takeda
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; Gilead Sciences; Janssen; Novartis; Takeda
Speakers' Bureau - Takeda
Travel, Accommodations, Expenses - Kite/Gilead
Other Relationship - Celgene; Gilead Sciences; Roche; Sanofi; Takeda
 
Alexia Francesca Bertuzzi
No Relationships to Disclose
 
Joan Brunet
Consulting or Advisory Role - AstraZeneca Spain; MSD Oncology
Travel, Accommodations, Expenses - GlaxoSmithKline
 
Gianpiero Rizzo
No Relationships to Disclose
 
Marta Perachino
No Relationships to Disclose
 
Alvin Jun Xing Lee
No Relationships to Disclose
 
Amani Chowdhury
No Relationships to Disclose
 
Isabel Ruiz-Camps
No Relationships to Disclose
 
Andrea Plaja
No Relationships to Disclose
 
Georgina Helen Hanbury
No Relationships to Disclose
 
Mieke Van Hemelrijck
No Relationships to Disclose
 
Nikolaos Diamantis
No Relationships to Disclose
 
Gianluca Gaidano
No Relationships to Disclose
 
Federica Grosso
Honoraria - Boehringer Ingelheim; Bristol Meyer Squibb; MSD Oncology; Novartis; Novocure; PharmaMar; Pierre Fabre
Consulting or Advisory Role - Bristol Meyer Squibb; MSD Oncology; Novartis; Novocure; PharmaMar; Pierre Fabre
Speakers' Bureau - Novocure
Travel, Accommodations, Expenses - Boehringer Ingelheim; Bristol Meyer Squibb; Novartis; novocure; PharmaMar
 
Alessandra Gennari
Honoraria - Daiichi Sankyo Europe GmbH; Eisai Europe; Lilly; Novartis; Roche
Speakers' Bureau - Eisai Europe
 
Josep Tabernero
Consulting or Advisory Role - Array BioPharma; AstraZeneca; Avvinity; Bayer; Boehringer Ingelheim; Chugai Pharma; Daiichi Sankyo; F. Hoffmann LaRoche; Genentech; HalioDx; Hutchison MediPharma; Ikena Oncology; Inspirna; IQvia; Lilly; Menarini; Merck Serono; Merus; Mirati Therapeutics; MSD; Neophore; Novartis; Ona Therapeutics; Orion Biotechnology; Peptomyc; Pfizer; Pierre Fabre; Samsung Bioepis; Sanofi; Scandion Oncology; Seagen; Servier; Sotio; Taiho Pharmaceutical; Tessa Therapeutics; TheraMyc
Other Relationship - Imedex; Medscape; MJH Life Sciences; Peerview; Physicans' Education Resource
 
David J. James Pinato
Honoraria - Avammune; Bristol-Myers Squibb; Da Volterra; Mursla Bio; Roche/Genentech
Consulting or Advisory Role - AstraZeneca; Da Volterra; Eisai; H3 Biomedicine; Ipsen; Mina Therapeutics; Roche
Speakers' Bureau - Bayer; Falk Pharma; Roche; ViiV Healthcare
Research Funding - Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); MSD Oncology (Inst)
Travel, Accommodations, Expenses - Bayer; Bristol-Myers Squibb; MSD Oncology
Other Relationship - Wiley